Trial Profile
Nimotuzumab in Combination With Radiochemotherapy for Patients With Stage IIIA/IIIB Non-small Cell Lung Cancer
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 16 Jan 2020
Price :
$35
*
At a glance
- Drugs Nimotuzumab (Primary) ; Cisplatin; Etoposide
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Sponsors Biotech Pharmaceutical
- 18 Sep 2015 New trial record